trans-1-N-(Quinazolin-4-yl)cyclohexane-1,4-diamine dihydrochloride -

REF #: 54-OR306411
Short description

trans-1-N-(Quinazolin-4-yl)cyclohexane-1,4-diamine dihydrochloride

Discover the exceptional versatility of trans-1-N-(Quinazolin-4-yl)cyclohexane-1,4-diamine dihydrochloride, a premium Building Block compound with a molecular weight of 315.24g/mol. This high-purity chemical, with the reference number 54-OR306411, offers a unique blend of reactivity and stability, making it an invaluable tool for advanced research and synthesis. Crafted with meticulous attention to detail, this compound boasts an HS code of 29223900, ensuring seamless integration into your laboratory workflows. Unlock the potential of this exceptional Building Block and elevate your experiments to new heights of precision and performance.

  • CAS: Not Available
  • Molecular Weight: 315.24g/mol
  • MDL: MFCD22378479
  • HS Code: 29223900
  • Hazard Information: TBC
Quantity :
  • Procurenet Team Tshim Sha Tsui
    Hong Kong Hong Kong 3 years
Description

trans-1-N-(Quinazolin-4-yl)cyclohexane-1,4-diamine dihydrochloride

Unlock the versatile potential of trans-1-N-(Quinazolin-4-yl)cyclohexane-1,4-diamine dihydrochloride, a meticulously crafted chemical compound that holds the key to unlocking new frontiers in scientific research and development. This highly pure and specialized molecule, identified by the Ref # 54-OR306411, boasts a unique chemical structure that makes it a valuable asset across diverse fields, from pharmaceuticals to material science.

At the heart of this compound lies a quinazoline core, fused with a cyclohexane ring and bearing two amine functionalities. This intricate arrangement of atoms and functional groups endows trans-1-N-(Quinazolin-4-yl)cyclohexane-1,4-diamine dihydrochloride with a remarkable versatility, allowing it to serve as a versatile building block in the synthesis of a wide range of innovative compounds and materials.

Pharmaceutical Prowess

In the realm of pharmaceutical research, this compound shines as a crucial starting material in the development of novel drug candidates. Its quinazoline scaffold and diamine moiety provide a solid foundation for the construction of complex molecular structures, enabling researchers to explore new therapeutic avenues and address a broad spectrum of health conditions. The strategic placement of the amine groups and the presence of the cyclohexane ring offer opportunities for targeted modifications, unlocking the potential for enhanced pharmacological properties, improved bioavailability, and increased therapeutic efficacy.

Researchers in the pharmaceutical industry can harness the unique characteristics of trans-1-N-(Quinazolin-4-yl)cyclohexane-1,4-diamine dihydrochloride to drive the discovery and development of cutting-edge pharmaceuticals, addressing unmet medical needs and improving patient outcomes.

Material Science Innovations

Beyond the pharmaceutical realm, this compound also finds its niche in the field of material science. Its distinct chemical structure, with the combination of the quinazoline core, cyclohexane ring, and amine functionalities, allows for the creation of novel materials with tailored properties. Researchers in this domain can leverage the versatility of trans-1-N-(Quinazolin-4-yl)cyclohexane-1,4-diamine dihydrochloride to engineer advanced polymers, coatings, or functional materials with enhanced thermal stability, mechanical strength, or optical characteristics.

The ability to incorporate this compound into diverse material systems opens up a world of possibilities, from the development of high-performance composites to the design of innovative smart materials. Material scientists can harness the unique attributes of trans-1-N-(Quinazolin-4-yl)cyclohexane-1,4-diamine dihydrochloride to push the boundaries of what's possible, unlocking new avenues for technological advancements.

Technical Specifications

  • Molecular Weight: 315.24g/mol
  • MDL Number: MFCD22378479
  • HS Code: 29223900
  • Hazard Information: TBC

To ensure the highest quality and purity, trans-1-N-(Quinazolin-4-yl)cyclohexane-1,4-diamine dihydrochloride is meticulously synthesized and rigorously tested. Its molecular weight of 315.24g/mol, along with the unique MDL number MFCD22378479, provide a clear identification for researchers seeking this specialized compound. The HS code 29223900 further classifies this product for international trade and regulatory purposes.

While the specific hazard information is yet to be confirmed (TBC), it is essential to handle this compound with the utmost care, following standard laboratory safety protocols. Proper personal protective equipment and well-ventilated work environments are crucial when working with this material.

Specifications
  • Hazard info: TBC
  • Hs code: 29223900
  • Mdl: MFCD22378479
  • Molecular weight: 315.24g/mol
All categories
Filters